KeQian Biotech: Net profit of 419 million yuan in 2025, a year-on-year increase of 9.51%

2026-04-10 18:43:06

Keqian Biology announces that in 2025, operating revenue will be 950 million yuan, a year-on-year increase of 0.83%. Net profit will be 419 million yuan, a year-on-year increase of 9.51%. The company plans to distribute profits in 2025 based on the total share capital registered on the equity distribution record date, with a cash dividend of 6.4 yuan (including tax) for every 10 shares to all shareholders.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.